2021-12-31-accounts - Heart Research UK

This text was generated using OCR and may contain errors. Check the original PDF to see the document submitted to the regulator.

						Page
Legal and administrative		information
Message from	our Chairman
Report ofthe	Trustees
Report ofthe	independent		Auditors			19
Consolidated	statement	of	financial	activities		23
(incorporating	statutory	income &		expenditure	account)
Consolidated	balance sheet					24
Charity balance sheet						26
Consolidated	cash flow	statement		and note		28
Notes to the	financial statements					29

LEGAL AND ADMINISTRATIVE INFORMATION	LEGAL AND ADMINISTRATIVE INFORMATION	LEGAL AND ADMINISTRATIVE INFORMATION	LEGAL AND ADMINISTRATIVE INFORMATION	LEGAL AND ADMINISTRATIVE INFORMATION
President Mr Richard Helmsley				MA FCA
Vice Presidents Cllr Brian		Cleasby				Patrons			Mr John	Bill
Mr Fabian		Hamilton	MP						Mrs Anne		Bill
Prof Shervanthi Homer-Vanniasinkam									Chnstopher			Kane
IBSc,MBBS, FRCSE, FRCS									Tammy	Kane
									Mark Bonnar
									Paul Insect
									Robert Smith
Past Presidents Mr David		A Watson MBE FRCS
Mr Keith		Louden OBE
Trustees
Chairman					Vice Chairman
Mr Paul Rogerson CBE DL					Ms Julie	Fenwick MSc
Mr Pierre Bouvet LLB
Mr Peter C Braidley MBBS	FRCS (Eng) FRCS (CTh)
Mr James Breeze B.Sc.(Hans.		) DipM ACIM
Mr Richard J Brown FCA
Dr Catherine J Dickinson MA		PhD FRCP
Dr David F Dickinson MB ChB DCH FRCP
Mr Anthony D Knight
Mrs Linda lylundoza CIPD (from 20 October 2021)
Prof Christopher Newman	MA PhD FRCP
Mr Kevin GWatterson MB	BSFRACS
Mr Richard C Hemsley MA	FCA (retired		24June 2021)
Mr Anthony R Kilner LLB (retired 24June				2021)
Mr Paul Smith FCSI (retired	7 March 2022)
Principal Officers:
Ms Kate Bratt-Farrar					Chief Executive			Officer
Dr Phil Newby BSc (Hons) MSc PhD					Head of Finance			(Company		Secretary)
Registered Ofgce &Head	Offic:				Regional office:
Suite 12D					13St Paul's Square
Joseph's Well					Birmingham
Leeds LS3 1AB					831RB
Teh 01132347474					Teh 0121454		1799
Email: info@heartresearch.		org.uk			Email: midlands@heartresearch.							org.uk
Independent Auditors:					Stockbrokers		and		Investment			Managers:
BHP LLP					J M Finn &Co		Ltd
1st Floor Mayesbrook House					4Coleman Street
Lawnswood Business Park					London
Leeds LS166QY					EC2R STA
Bankers:					Solicitors.
Barclays Bank PLC					Walker	Morris		LLP
Barclays Business Centre					Kings Court
Albion Street					12King	Street
Leeds LS1 1PA					Leeds LS12HL

				Unrestricted	Restricted	Total	Total
				funds	funds	funds	funds
				2021	2021	2021	2020
			Note	6	6	6	E
income from:
Donations and legacies				2,256,447	74,809	2,331,256	2,448,853
Sponsored events				58,666	32,261	90,927	121,664
Trading subsidiary				144,061		144,061	1,604
investments				164,837		164,837	171,316
Total income				2,624,011	107,070	2,731,081	2,743,437
Expenditure on:
Raising funds			6	468,042	4,968	473,010	422,390
Charitable activities			7	2,937,924	166,643	3,104,567	1,166,799
Totalexpenditure				3,405,966	171,611	3,577,577	1,589,189
Net (expenditure)/income		before net
gains on investments				(781,955)	(64,541)	(846,496)	1,154,248
Net gains on investments				759,564		759,564	279,169
Net (expenditure)/income				(22,391)	(64,541)	(86,932)	1,433,417
Transfers between	funds		21	6,506	(6,506)
Net movement In funds				(15,885)	(71,047)	(86,932)	1,433,417
Reconciliation offunds:
Total funds brought	forward			6,691,748	221,617	6,913,365	5479 948
Net movement in funds				(15,885)	(71,047)	(86,932)	1,433,417
Total funds carried	forward			6,675,863	150,570	6,826,433	6,913,365

				2021	2020
			Note	6	6
Cash flows from operating activities
Net cash generated by operating activities			24	1,384,050	150,186
Cash flows from investing activities
Movement in investment broker cash				(256,091)	(135,931)
Dividends and interest received				154,257	165,194
Purchase ofintangible assets				(1,068)
Proceeds from 's'ale ofinvestments				488,303	1,374,507
Purchase ofinvestments				(1,366,134)	(1,188,048)
Net cash (used in)/provided by investing		activities		(980,733)	215,722
Change in cash and cash equivalents	in the year			403,317	365,908
Cash and cash equivalents at the beginning		ofthe year		1,815,824	1,449,916
Cash and cash equivalents atthe end	ofthe year		25	2,219,141	1,815,824

		Unrestricted	Restricted	Total	Tota I
		funds	funds	funds	funds
		2021f	2021 f	2021 f	2020f
Donations		248,273	73,309	321,582	285,159
Legacies		2,008,174	1,500	2,009,674	2,107,266
Coronavirus	Job Retention Scheme Grant				56,428
Total 2021		2,256,447	74,809	2,331,256	2,448,853
Total 2020		2,341,470	107,383	2,448,853
Investment	income
			Unrestricted	Total	Total
			funds	funds	funds
			2021f	2021 f	2020f
Income from	fixed asset investments		148,498	148,498	122,588
Income from	current asset investments		5,759	5,759	42,606
Bank and other interest			10,580	10,580	6,122
Total 2021			164,837	164,837	171,316
Total 2020			171,316	171,316

			Unrestricted	Restricted	Total	Total
			funds	funds	funds	funds
			2021	2021	2021	2020
			E	6		E
Postage			8,889	116	9,005	5,634
Advertising	publicity &	event costs
Legacy related			840		&40	5,050
Event related			6,235	3,800	10,035	28,252
General			7,033	975	8,008	9,824
Other fundra	ising costs		8,341	77	8,418	7,471
tegrrl and professional
Legacy related			5,190		5,190	2,919
Investment	management	costs	57,783		57,783	51,947
Apportioned	support costs:
Operating lease rentals			27,284		27,284	13,897
Other premises costs			11,516		11,516	6,230
Telephone			2,645		2,645	1,184
Training			8,670		8,670	2,097
Information	technology		27,739		27,739	15,511
Marketing			18,393		18,393	23,758
Othercosts			20,345		20,345	31,217
Wages and	salaries		217,601		217,601	184,999
Social security costs			18,971		18,971	16,576
Pension costs			20,567		20,567	15,824
Total2021			468,042	4,968	473,010	422,390
Total 2020			421,845	545	422,390

			Unrestricted	Restricted	Total	Tota I
			funds	funds	funds	funds
			2021	2021	2021	2020
			6	6	6	f
Grants
Medical research grants awarded			1,999,856	36,749	2,036,605	293,551
Grants awarded		in previous years no longer
required			(8,360)		(8,360)	(112,349)
Healthy Hearts		grants awarded		118,451	118,451
Grants awarded		in previous years no longer
required			(1,772)	(1,425)	(3,197)	(8,443)
Direct support		costs
Medical research			71,124	11,026	82,150	27,371
Prevention	and	education	54,394	790	55,184	185,982
Prevention	and	education -staff costs	197,397		197,397	36,430
Trading corn	pa	ny	72,569		72,569	6,898
Dissemination		ofinformation
Production	of 'Pulse'		2,345		2,345
Web-site maintenance			2,826	30	2,856	3,358
Apporterned	support costs:
Staff costs			327,853		327,853	506,535
Operating lease rentals			34,787		34,787	32,379
Other premises		costs	14,683		14,683	14,516
Telephone			3,373		3,373	2,761
Training			10,975	79	11,054	4,887
information	technology		24,001		24,001	13,421
Marketing			15,831	85	15,916	20,556
Other costs			17,203	858	18,061	27,011
Governance	costs (note 8)		98,839		98,839	111,935
Total 2021			2,937,924	166,643	3,104,567	1,166,799
Total 2020			1,132,923	33,876	1,166,799

				Unrestricted	Total	Total
				funds	funds	funds
				2021	2021	2020
				8	6	E
Auditor's remuneration				14,033	14,033	11,640
Legal, professional		and consultancy	fees	2,444	2,444	3,583
Trustee indemnity		insurance		529	529	529
Trustee meeting expenses				272	272	154
Other governance		costs		1,654	1,654
Apportioned	support costs
Staff costs				57,856	57,856	76,461
Operating lease rentals				6,139	6,139	4,888
Other premises costs				2,591	2,591	2,191
Telephone				595	595	417
Training				1,951	1,951	738
lnfomation	technology			4,461	4,461	2,494
Marketing				2,958	2,958	3,820
Other costs				3,356	3,356	5,020
Total 2021				98,839	98,839	111,935
Total 2020				111,935	111,935

					Total	Total
		Staff costs	Depreciation	Other costs	funds	funds
						2020
			6	8		f
Raising funds		257,139	1,027	214,844	473,010	422,390
Charitable	activities	583,106	1,054	2 520 407	3,104,567	1,166,799
Total 2021		840,245	2,081	2,735,251	3,577,577	1,589,189
Total 2020		836,825	4,216	748,148	1,589,189

				Charitable		Total	Total
			Raising funds	activities	Governance	funds	funds
							2020
							6
Staff costs			257,139	327,853	57,856	642,848	800,395
Premises (including rates)	rent	and	38,800	49,470	8,730	97,000	74,101
Telephone			2,645	3,373	595	6,613	4,362
Training			8,670	11,054	1,951	21,675	7,722
lnfomation technology depreciation)		(including	27,739	24,001	4,461	56,201	31,426
Marketing			18,393	15,916	2,958	37,267	48,134
Other costs			20,345	18,061	3,356	41,762	63,248
Total 2021			373,731	449,728	79,907	903,366	1,029,388
Total 2020			311,293	622,066	96,029	1,029,388

					Group		Group	Group	Charity	Charity
					2021			2020	2021	2020
					g				6	6
Wages and salaries					717,181		712,664		717,181	712,664
Social security	costs				63,297		64,175		63,297	64,175
Contribution	to defined contdibution		pension
schemes					59,767		59,986		59,767	59,986
					840,245		836,825		840,245	836,825
The average number ofpersons employed				by the charity	during the	year	was	as follows:
									Group	GI'0 up
									2021	2020
									No.	No.
Administration,	management,	fundraising		and charitable	expenditure	support			27	26
The number ofemployees whose employee				benefits (excluding employer			pension costs)		exceeded f60000was:
									Group	Group
									2021	2020
									No.	No.
ln the band 660,001 - 670,000									1	1

Intangible assets
Group
		App
		Development
		E
Cost
At 1January 2021		50,000
At 31December 2021		50,000
Amortlsatl on
Charge for the year		50,000
At 31December 2021		50,000
Net book value
At 31December 2021
At 31December 2020		50,000
The charity has Enil intangible	fixed assets (2020:Enil).

13.	Tangible fixed assets
	Group
		Office
		equipment
		6
	Costor valuation
	At 1January 2021	&8/31
	Additions	1,068
	At 31December 2021	89,499
	Depreciation
	At 1January 2021	84,268
	Charge for the year	2,081
	At 31December 2021	86,349
	Net book value
	At 31December 2021	3,150
	At 31December 2020	4,163

Charity
	Office
	equipment
	6
Cost or valuation
At 1January 2021	88,169
Additions	1,068
At 31December 2021	89,237
Depreciation
At 1January 2021	84,006
Charge for the year	2,081
At 31December 2021	86,087
Net book value
At31December 2021	3,150
At 31December 2020	4,163

			Quoted	Total	Total
			investments	funds	funds
			2021f	2021f	2020f
Group
Market value
At 1January 2020			5,709,810	5,709,810	5,456,770
Additions at cost			1,416,116	1,416,116	1,188,048
Disposal proceeds			(448,303)	(448,303)	(1,374,507)
Net realised and unrealised	gains/ (losses)		696,241	696,241	439,499
At31December 2021			7,373,864	7,373,864	5,709,810
Cash awaiting reinvestment			385,387	385,387	127,840
			7,759,251	7,759,251	5,837,650
		Quoted	Investment in	Total	Total
		investments	subsidiary	funds	funds
		2021 f	2021 f	2021f	2020 f
Company
Market value/cost
At 1January 2020		5,709,810	100	5,709,910	5,456,870
Additions at cost		1,416,116		1,416,116	1,188,048
Disposal proceeds		(448,303)		(448,303)	(1,374,507)
Net realised and unrea lised	gains/ (losses)	696,241		696,241	439,499
At31December 2021		7,373,864		7,373,964	5,709,910
Cash awaiting reinvestment		385,387		385,387	127,840
		7,759,251	100	7,759,351	5,837,750

			Group	Group
			2021	2020
			E	E
Finished goods			6,754	7,348
The chadty held no stock at the year end (2020:fNIL)
Debtors
	Group	Group	Charity	Charity
	2021 f	2020 F.	2021 f	2020f
Due after more than one year
Amounts owed by group undertakings				46,000
				46,000
Due within one year
Trade debtors			100
Amounts owed by group undertakings			84,239	37,344
Otherdebtors	1,606	854	1,293	854
Prepayments and accrued income	95,442	66,986	95,442	66,986
Legacies receivable	1,106,827	1,496,808	1,106,827	1,496,808
	1,203,975	1,564,648	1,287,901	1,647,992

		Group	Group	Charity	Charity
		2021f	2020f	2021f	2020f
Listed	investments		1,119,820		1,119,820

18.	Creditors: Amounts falling due	Creditors: Amounts falling due	within one year	within one year
				Group	Group	Charity	Charity
				2021f	2020f	2021f	2020 f
	Trade creditors			21,623	44,268	21,623	44,268
	Other creditors			4,267	2,750	4,267	2,742
	Accruals and deferred	income		32,680	25,798	30,070	24,643
	Grants accrued (see note 20)			3,034,947	2,325,992	3,034,947	2,325,992
				3,093,517	2,398,808	3,090,907	2,397,645
19.	Creditors: Amounts falling due		after more than one year
				Group	Group	Charity	Charity
				2021	2020f	2021 f	2020 f
	Grants accrued (see	note 20)		1,272,321	1,087,280	1,272,321	1,087,280
20.	Reconciliation ofgrants accrued
						2021	2020
						f	f
	Opening liability obligation					3,413,812	4,179,228
	Medicalresearch grants awarded			in year		2,036,605	293,551
	Healthy Heart grants	awarded	in	the year		117,221
	Provisions no longer	required	by	grantees		(10,327)	(120,792)
	Paid during the year					(1,250,043)	(938,175)
	Closing liability obligation					4,307,268	3,413,812

Statement offunds
Statement offunds	- current year
	Balance at 1			Transfers	Gains/	Balance at 31
	January 2021 6	Income 6	Expenditure 6	In/out 6	(Losses) 6	December 2021 6
Unrestricted
funds
Designated funds
HRUK Heart
Academy	19,054		(19,054)
Translational
Research
Projects-
Scotland	32,308		(32,308)
Future Grants
fund	3,754,253		(1,953,6801			1,800,573
	3,805,615		(2,005,042)			1,800,573
Genenrl funds
General Funds - all
funds	2,886,133	2,624,011	(1,400,924)	6,506	759,564	4,875,290
Total Unrestricted
funds	6,691,748	2,624,011	(3,405,966)	6,506	759,564	6,675,863

	Balance at 1				Transfers	Gains/	Balance at31
	ianuary 2021	income f	Expenditure	f	in/out f	(Lussesi f	December 2021 f
Restricted funds
Subways	158,658	17,678	(117,026)				59,310
Heart Camps	20,498						20,498
The Mick Grainger
In-Memory
Masterclass	20,291	9,814					30,105
Aortic Arch
Masterclass	12,042	13,499	(15,798)				9,743
HOS / RESSCO-
Scotland		36,749	(36,749)
PhO Studentship
(Caravan Guard)		18,614					18,614
Other	10,128	10,716	(2,038)		(6,506)		12,300
	221,617	107,070	(171,611)		(6,506)		150,570
Totaloffunds	6,913,365	2,731,081	(3,577,577)			759,564	6,826,433

Statement of	funds	(continued)
Statement of	funds	- prior year
		Balance	at					Balance at
		13anuary				Transfers	Gains/	31December
		2020		income	Expenditure	in/out	(Losses)	2020
			E		6	E	6	6
Unrestricted
funds
Designated funds
HRUK Heart
Academy		163,654			(144,600)			19,054
Translational
Research
Projects-
Scotland		181,997			(59,976)	(89,713)		32,308
Future Grants
fund		1,800,000			(194,887)	2,149,140		3,754,253
		2,145,651			(399,463)	2,059,427		3,805,615
General funds
General Funds	—all
funds		3,158,661		2,629,103	(1,155,306)	(2,025,494)	279,169	2,886,133
Total Unrestricted
funds		5,304,312		2,629,103	(1,554,769)	33,933	279,169	6,691,748

	Balance at					Balance at
	1january			Transfers	Gains/	31December
	2020 E	Income E	Expenditure E	in/out E	(Losses) f	2020 'f
Restricted funds
Subwaya	125,434	26,426	6,798			158,658
Heart Camps	20,498					20,498
The Mick Grainger
In-Memory
Masterclass	17,011	3,280				20,291
Aortic Arch
Masterclass	6,942	5,105	(5)			12,042
Research-
Scotland		35,855	(35,934)	79
Other	5,751	43,668	(5,279)	(34,012)		10,128
	175,636	114,334	(34,420)	(33,933)		221,617
Total offunds	5,479,948	2,743,437	(1,589,189)		279,169	6,913,365

Summary	offunds	- current year
		Balance at 1			Transfers	Gains/	Balance at 31
		January 1021 f	Incomef	Expendituref	in/outf	(Losses) f	December 1011
Designated	funds	3,805,615		(2,005,042)			1,800,573
General funds		2,886,133	2,624,011	(1,400,924)	6,506	759,564	4,875,290
Restricted	funds	221,617	107,070	(171,611)	(6,506)		150,570
		6,913,365	2,731,081	(3,577,577)		759,564	6,826,433
Summary	offunds	- prior year
		Balance at					Balance at
		1January			Transfers	Gains/	31December
		2020 f	Income f	Expenditure f	in/outf	(Losses) E	2020 f
Designated	funds	2,145,651		(399,463)	2,059,427		3,805,615
General funds		3,158,661	2,629,103	(1,155,306)	(2,025,494)	279,169	2,886,133
Restricted	funds	175,636	114,334	(34,420)	(33,933)		221,617
		5,479,948	2,743,437	(1,589,189)		279,169	6,913,365

Analysis ofnet assets between funds -current year
	Unrestricted	Restricted	Total
	funds	funds	funds
	2021f	2021f	2021f
Tangible fixed assets	3,150		3,150
Fixed asset investments	7,759,251		7,759,251
Current assets	3,279,300	150,570	3,429,870
Creditors due within one year	(3,093,517)		(3,093,517)
Creditors due in more than one year	(1,272,321)		(1,272,321)
Total	6,675,863	150,570	6,826,433

Analysis ofnet assets between	funds (continued)
Analysis ofnet assets between	funds - prior year
		Unrestricted		Restricted	Total
			funds	funds	funds
			2020 f	2020 6	2020f
Tangible fixed assets			4,163		4,163
Intangible fixed assets			50,000		50,000
Fixed asset investments		5,837,650			5,837,650
Current assets		4,286,023		221,617	4,507,640
Creditors due within one year		(2,398,808)			(2,398,808)
Creditors due in more than one year		(1,087,280)			(1,087,280)
Total		6,691,748		221,617	6,913,365
Reconciliation ofnet movement	in funds to net cash flow from operating		activities
				Group	Group
				2021	2020
				6	6
Net income/expenditure for the	year (as per Statement of Financial Activities)			(86,932)	1,433,417
Adjustments for:
Depreciation charges				2,081	4,216
Impairment charge				50,000
Gains/(losses) on investments				332,141	(282,945)
Dividends and interest from investments				(154,257)	(165,194)
Loss on the sale offixed assets					53
Decrease in stocks					660
Decrease/(increase) in debtors				360,673	(71,493)
Increase/(decrease) in creditors				879,750	(768,528)
Net cash generated hy openrting	activities			1,384,050	150,186

	Group	Group
	2021	2020
		6
Cash in hand	246,297	144,427
Notice deposits (less than 3 months)	1,972,844	1,671,397
Total cash and cash equivalents	2,219,141	1,815,824

	Group	Group
	2021	2020
		6
Group ond company
Within 1year	65,521	63,271
Between 1and 5years	1,461	64,252
	66,982	127,523

Group	Group
2021	2020
6
72,271	62,410

NOTES TO THE FINANCIAL STATEMENTS	NOTES TO THE FINANCIAL STATEMENTS	NOTES TO THE FINANCIAL STATEMENTS	NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2021
Grants awarded 2021
													2021
Medical Research and	Trustee Discretionary					Gnrnts
Cambridge
University ofCambridge
Prof Ziad Mallat
The effect of low-dose interleukin-2			on human					atherosclerotic	plaque immune		cells at single cell
resolution													191/76
Oxford
University ofOxford
Prof Regent Lee
Using deep learning	methods to generate				contrast enhanced				computerised	tomography
angiography without	the use ofintravenous					contrast agents							246,226
London
King's College London
Dr Nilesh Pareek
Developing a digital handover application prehospital stratification for OOHCA -the					for paramedics to provide a personalized RAPID MIRACLE study							approach to	248,110
King's College London
Prof Jaswinder Gill
Sleep-disordered breathing		and arrhythmias					(clinical)						87,000
Edinburgh
University of Edinburgh
Prof Gillian Gray
Mass spectrometry imaging		to illuminate		the			activity of118-hydroxsteroid			dehydrogenase
1inhibitors and their	potential for repurposing							to prevent heart failure development				after
myocardi a I infa rcti on													88,568
Dundee
University of Dundee
Prof Faisel Khan
Inflammatory drivers	ofendothelial		dysfunction					in COVID-19					133,693
Glasgow
University ofGlasgow
Prof Sandosh Padmanabhan
Vascular effects ofSARS-COV-2 infection				and			long term impact on hypertension						250,000
University ofGlasgow
ProfJesse Dawson
Preventing Recurrent Study)	Cardioembolic		Stroke			—New Blood Tests and Risk Prediction						(The PRECISE	115,811
Grants awarded 2021	corned	fonuard											1,36020ut

NOTES TO THE FINANCIAL	STATEMENTS	STATEMENTS	STATEMENTS	STATEMENTS	STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2021
Grants awarded 2021(continued)
															2021
															E
Grants awarded 2021brought forward															1,360,884
Manchester
University of Manchester
Dr Delvac Oceandy
Pharmacological inhibition of		Hippo pathway				forthe treatment				ofadverse cardiac				remodelling	151,203
Leeds
Leeds Teaching Hospital	NHS Trust
Ms Carin Van Doom
Gerlis Heart Collection															5,500
Bristol
University of Bristol
Prof Paolo Madeddu
Targeting pericytes for	halting		pulmonary hypertension					in infants with congenital						heart disease	145,233
Newcastle
Newcastle University
Prof Loakim Spyridopoulos
Tcell immunity and myocardial				inflammation			in patients	recovering			from COVID-19 infection				147,649
South Tees
South Tees NHS Hospitals	Foundation
Akowuah
Pre-habilitation in elderly patients					undergoing		cardiac surgery								41,617
ulster
Ulster University
Escalona
Minimal tissue heating	effects		technology for				wireless energy			supply to implanted				ventricular
assist devices in the treatment				ofheart failure											1,000
London
Kings College London
Ellison-Hughes
Targeting cellular senescence as a therapy to cardiomyocytes and endothelial cells							rejuvenate	the	reparative			activity	of	human	14,634
Glasgow
University ofGlasgow
Taylor
implementation ofan	evidence-based cardiac						rehabilitation		home		programme		for heart failure		23,400
patients and their caregivers		in		Scotland: SCOTrREACH-H				Fproject
Grants awarded 2021carried forward															1,891,120

HRUK &Subway Healthy Heart Grants	2021(co	nti	nued)
										2021
HRUK &Subway Grants brought forward										94,493
Scotland
Nutrition Scotland
Mrs Suzanne Fletcher
Corkerhill Healthy Hearts Programme	-The Corkerhill			Healthy	Hearts programme			consists of
cooking and nutrition classes. Group members		will learn about a different					nutritional		topic each
week, culminating in them cooking a heart healthy meal together.						Digital resources			will also be
created, expanding the reach ofthis project.										9,643
Northern Ireland
Newtownstewart Leisure Complex Ltd
Mrs Irene Spratt
Healthy Hearts &Healthy Minds - Community		Kitchen		Hub &Exercise - The Healthy					Hearts and
Minds project aims to actively reduce	the risk	of	heart	disease	in a deprived		area	of
Newtownstewart through the delivery	ofhealthy		cooking and		physical activity sessions aimed at
both adults and children.										9,955
Harryville Men's Shed
Mr Denver McMeekin
Harryville Men's Walking Football - The Haryville			Men's Walking Football project					targets older
men in Ballymena, Northern Ireland. This project			aims	to get men		active through		a walking
football and healthy eating programme.										4,360
HRUK &Subway Grants awarded 2021										118,451
Grants written back										(3,197)
Total HRUK &Subway Grants Awarded	2021									115,254

Subsidiary name	Subsidiary name	Subsidiary name		Company	Basis of	Equity
				number	control	shareholdlng
HRUK Helping		Hearts Limited		01562684	Direct		100%
The financial	results ofthe subsidiary		for the year were:
Name			income	Expenditure	Profit/(Loss)	Net	assets
				6	forthe year		E
					E
HRUK Helping		Hearts Limited	144,061	P4,919)	69,142	53,431